|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 327.10 CHF | +0.77% |
|
-0.67% | -0.34% |
| Jun. 05 | Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial | RE |
| Jun. 05 | Zealand touts promising tolerability data for obesity drug in mid-stage study | RE |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 17.55x | 6.47x | 1.08x | 4.34x | 10.65x | 12.11x | 3.07% | 328B | ||
| 33.11x | 19.76x | 0.68x | 12.04x | 24.78x | 25.27x | 0.6% | 1,009B | ||
| 24.88x | 6.26x | -1.64x | 5.74x | 15.6x | 17.25x | 2.29% | 560B | ||
| 27.82x | -827.16x | 0.11x | 6.77x | 13.84x | 14.22x | 3.02% | 401B | ||
| 23.42x | 5.41x | 1.12x | 4.85x | 13.81x | 14.45x | 1.8% | 288B | ||
| 20.62x | 6.16x | -172.85x | 5.32x | 12.95x | 14.12x | 3.06% | 272B | ||
| 12.56x | 5.5x | -6.76x | 4.71x | 9.62x | 11.3x | 4% | 194B | ||
| 22.73x | 16.95x | 2.81x | 6.08x | 10.62x | 13.92x | 2.89% | 189B | ||
| -46.22x | 8.77x | 0.33x | 5.58x | 31.48x | 62.73x | 2.51% | 160B | ||
| 12.18x | 1.69x | 0.21x | 3.19x | 7.76x | 9.34x | 6.73% | 148B | ||
| 11.22x | 4.97x | 0.24x | 3.08x | 8.22x | 8.93x | 4.39% | 117B | ||
| 25.55x | 5.13x | 1.8x | 7.72x | 17.4x | 18.12x | -.--% | 113B | ||
| 11.39x | 1.24x | 1.65x | 2.25x | 7.34x | 8.14x | 5.5% | 108B | ||
| 12.42x | 4.26x | 1.18x | 2.66x | 7.82x | 8.78x | 3.61% | 103B | ||
| 24.33x | 5.54x | 1.37x | 8.3x | 15.68x | 16.4x | 1.81% | 77.57B | ||
| 43.84x | 1.09x | 0.68x | 2.59x | 9.55x | 27.07x | 4.06% | 48.56B | ||
| 33.47x | 4.52x | 1.74x | 7.41x | 24.62x | 27.92x | 0.58% | 46.02B | ||
| 15.47x | 1.26x | -0.09x | 1.48x | 7.01x | 11.7x | 0.61% | 41.02B | ||
| 39.59x | 19.03x | 0.17x | 6.69x | 29x | 29.09x | -.--% | 40.46B | ||
| 17.59x | 1.75x | 4.97x | 3.23x | 12.18x | 13.65x | 2.36% | 39.94B | ||
| Average | 19.18x | -35.07x | -8.06x | 5.20x | 14.50x | 18.23x | 2.64% | 214.27B | |
| Weighted average by Cap. | 21.69x | -68.61x | -10.79x | 6.79x | 16.25x | 18.68x | 2.37% |
- Stock Market
- Equities
- ROP Stock
- Sector Roche Holding AG
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















